ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1932

Giant Cell Arteritis – the Relationship Between the Extensiveness of Vasculitis and the Clinical Presentation

Alojzija Hocevar1, Rok Jese1, Matija Tomsic1 and Ziga Rotar1, 1University Medical Center Ljubljana, LJUBLJANA, Slovenia

Meeting: ACR Convergence 2020

Keywords: giant cell arteritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2020

Title: Vasculitis – Non-ANCA-Associated & Related Disorders Poster II

Session Type: Poster Session D

Session Time: 9:00AM-11:00AM

Background/Purpose: Recent data show that the extensiveness of inflammation observed on colour Doppler ultrasonography (CDS) may indicate the risk for ocular ischaemia giant cell arteritis (GCA) patients. 1

The aim of our prospective study was to evaluate potential correlation between the clinical presentation of GCA and the extensiveness of vascular involvement assessed by CDS in preselected cranial and aortic arch arteries.

Methods: We performed CDS in incipient GCA patients between October 2013 and May 2020, using a Philips IU22 with 5–17.5 MHz linear probe or Philips Epiq 7 with 5–18.5 MHz linear probe. A total of 14 arteries were examined: bilateral temporal (main, frontal and parietal branch were considered as one vessel territory), facial, occipital, thyroid, carotid, vertebral, subclavian, and axillary arteries. A halo with positive compression sign was considered a positive finding. We explored correlations were explored between GCA clinical features and the number of involved vessels using Spearman test.

Results: During the 80-month observation period we diagnosed GCA in 267 patients (66.3% females, median (IQR) age 74.9 (67.0–80.4) years), median (IQR) symptom duration time 30 (21; 60) days). The CDS was positive in 263/267 (98.5%) patients in at least one of the examined arteries (range from 1 to 12). Table 1 shows the number of patients by number of involved vessels. 

We observed a very weak positive correlation between symptom duration and the number of affected vessels (0.14 (95%CI 0.02; 0.25), p=0.024), and very weak inverse correlation between headache and the number of affected vessels (-0.14 (95%CI -0.24;-0.02), p=0.023). There was no significant correlation between patient age, sex, the presence of constitutional symptoms, polymyalgia rheumatica, vision manifestations (including severe manifestations), jaw claudication, ESR, CRP, haemoglobin level, platelet count, and the extensiveness of vascular involvement in GCA.

Conclusion: In our incipient GCA cohort, we found no strong correlation between the extent of vascular involvement, assessed by CDS of cranial and aortic arch arteries, and clinical symptoms, but there was a trend for patients with longer symptom duration to have more extensive vessel involvement.

Reference: 1. van der Geest KSM, et al. ARD 2020;79:393–9. doi:10.1136/annrheumdis-2019-216343.

Table 1. Patients by the number of vessels involved on CDS examination


Disclosure: A. Hocevar, None; R. Jese, None; M. Tomsic, None; Z. Rotar, None.

To cite this abstract in AMA style:

Hocevar A, Jese R, Tomsic M, Rotar Z. Giant Cell Arteritis – the Relationship Between the Extensiveness of Vasculitis and the Clinical Presentation [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/giant-cell-arteritis-the-relationship-between-the-extensiveness-of-vasculitis-and-the-clinical-presentation/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/giant-cell-arteritis-the-relationship-between-the-extensiveness-of-vasculitis-and-the-clinical-presentation/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology